| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZEB1_0002800 | Intron-Intron | chr10:31630071-31630393 | chr10:31341142-31341464 | 323 nt | 0.3901 |
| hsa_ZEB1_0002900 | Intron-Intron | chr10:31631293-31631430 | chr10:31342364-31342501 | 138 nt | 0.3986 |
| hsa_ZEB1_0003100 | Intron-Exon-Intron | chr10:31634361-31644121 | chr10:31345432-31355192 | 238 nt | 0.3992 |
| hsa_ZEB1_0003200 | Intron-Exon-Intron | chr10:31634361-31647262 | chr10:31345432-31358333 | 235 nt | 0.4383 |
| hsa_ZEB1_0003000 | Intron-Exon-Intron | chr10:31634361-31676195 | chr10:31345432-31387266 | 250 nt | 0.3480 |
| hsa_chr10_0275500 | Intergenic-Intergenic | chr10:31636148-31642112 | chr10:31347219-31353183 | 250 nt | 0.3280 |
| hsa_ZEB1_0003300 | Intron-Exon-Intron | chr10:31636325-31676727 | chr10:31347396-31387798 | 250 nt | 0.3720 |
| hsa_chr10_0275600 | Intergenic-Intergenic | chr10:31640454-31640720 | chr10:31351525-31351791 | 267 nt | 0.2884 |
| hsa_ZEB1_0003400 | Intron-Exon-Intron | chr10:31642449-31647262 | chr10:31353520-31358333 | 1862 nt | 0.3319 |
| hsa_ZEB1_0003500 | Intron-Exon-Intron | chr10:31642449-31663893 | chr10:31353520-31374964 | 229 nt | 0.3057 |
A study in humans identified the circZEB1 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically validated [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in humans demonstrated that circZEB1 was upregulated in left atrial appendages of patients with atrial fibrillation [Tian et al. DOI:10.3390/molecules26041155].